A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the ...